QUBT insider files Form 144 to sell 9,360 shares
Quantum Biotechnologies (QUBT) filing to sell 9,360 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quantum Biotechnologies (QUBT) filing to sell 9,360 shares. The Form 144 reports the intended sale of 9,360 shares following an exercise of options under a registered plan dated 03/11/2026. The filing also shows prior sales of 68,902 shares on 03/10/2026.
Insights
Form 144 notifies of a planned disposition after option exercise.
The filing lists an intended sale of 9,360 shares on 03/11/2026 tied to an exercise of options under a registered plan. This is a regulatory notice that certain resale conditions and holding-period rules may apply.
Prior sales of 68,902 shares on 03/10/2026 are reported; subsequent filings will confirm actual settlement and any proceeds. Cash‑flow treatment and purchaser identity are not specified in the provided excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did QUBT disclose in this Form 144?
Who appears to be the selling party in the QUBT Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.